Please login to the form below

Not currently logged in


This page shows the latest Ridgeback news and features for those working in and with pharma, biotech and healthcare.

Merck and Ridgeback fulfil US deal for molnupiravir

Merck and Ridgeback fulfil US deal for molnupiravir

Merck &Co – known as MSD outside the US and Canada – and Ridgeback Biotherapeutics have announced that approximately 3.1 million courses of its investigational oral antiviral COVID-19 treatment, molnupiravir, have ... Speaking on behalf of Ridgeback

Latest news

More from news
Approximately 5 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...